Repotrectinib-impurities | Pharmaffiliates

Repotrectinib

Repotrectinib, sold under the brand name Augtyro, is an anti-cancer medication used for the treatment of non-small cell lung cancer. Reference standards of Repotrectinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Repotrectinib - API Standards
    [catalogue_number] => PA 18 1690000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 355.37
    [form] => C18H18FN5O2
    [cas] => 1802220-02-5
    [pslug] => 1802220-02-5-repotrectinib-api-standards-pa181690000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 1690000

Repotrectinib - API Standards


  • Catalogue No.:PA 18 1690000

  • CAS :

    1802220-02-5

  • Molecular Formula : C18H18FN5O2

  • Molecular Weight : 355.37